Organ Transplant Co.'s Q3 Revenues Rise 378%
Source: Streetwise Reports  (11/4/22)
Shares of medical technology firm TransMedics Group Inc. traded 24% higher to a new 52-week high after the company reported Q3/22 financial results highlighting a 378% YoY increase in net revenue and raised its FY/22 revenue estimates to US$80-85 million. More >

Robotic Surgical Device Co.'s Shares Rise on Q3 Earnings
Source: Streetwise Reports  (10/20/22)
Shares of Intuitive Surgical Inc. traded 9% higher yesterday after the robotic surgical device maker reported Q3/22 earnings that included an 11% YoY increase in revenue and a 13% YoY increase in its installed da Vinci Surgical System base. More >

Several Trials of Co.'s Fluid Pump To Read Out This Year
Source: Dr. Yi Chen  (9/14/22)
Positive topline data could boost the share price of this Swiss medical device firm, noted an H.C. Wainwright & Co. report. More >

Medtech Co. Meets Primary Endpoints in Ph. 3 Glaucoma Trials
Source: Streetwise Reports  (9/8/22)
Glaukos Corp.'s shares traded 18% higher yesterday after the company reported that in two separate Phase 3 trials, its iDose TR met its primary efficacy endpoints by lowering intraocular pressure in glaucoma patients. More >

Cardiovascular Device Co. On Pace to Double Revenue in FY22
Source: Streetwise Reports  (8/9/22)
Shares of Shockwave Medical Inc. traded 17% higher to a new 52-week high after the company advised that it posted a 116% YoY increase in revenue during Q2/22 and raised the midpoint for its FY/22 revenue guidance by $25 million to $465-475 million. More >

SRT Device Maker's Revenues Rise 124% in Q2
Source: Streetwise Reports  (8/5/22)
Sensus Healthcare Inc.'s shares traded 30% higher after the company reported it achieved a 124% YoY increase in revenue in Q2/22. The company advised that demand continues to remain strong for its superficial radiation therapy (SRT) devices which provide minimally invasive and non-surgical alternatives for non-melanoma skin cancer & keloid removal. More >

Ins. Provider to Offer Med Tech Co.'s CGM to its 45M Members
Source: Streetwise Reports  (8/4/22)
Shares of Senseonics Holdings Inc. traded 31.5% higher yesterday after the company reported that Elevance Health (formerly Anthem) has approved coverage of its Eversense® E3 implantable continuous glucose monitor to its forty-five million covered members. More >

MRI Device Maker's Earnings Come In at High End of Forecasts
Source: Streetwise Reports  (8/3/22)
IRadimed Corp. reported Q2/22 financial results that were modestly higher than expected. ROTH Capital Partners LLC advised in a research update that based on the company's higher revenues, improved margins and disciplined cost control measures it is maintaining its Buy rating on IRadimed and raising its price target to $42/share (up from $40). More >

Medical Device Firm Maintains Growth Momentum in Q2/22
  (7/21/22)
electroCore Inc.'s Q2/22 and H1/22 revenues are up quarter over quarter and year over year, respectively, and the upward trend is expected to continue through year-end 2022, noted an H.C. Wainwright & Co. report. More >

Laser Device Co. Gains FDA Approval for Next-Gen Catheter
Source: Streetwise Reports  (7/5/22)
Ra Medical Systems Inc. shares traded 36% higher after the firm reported it received U.S. FDA 510(k) clearance for its DABRA 2.0 Catheter. The DABRA 2.0 is incorporated into the company's DABRA Excimer Laser System which is used by vascular surgeons in procedures to treat lower extremity and peripheral vascular disease. More >

Trial Shows Colon Cleansing Device to Be Effective
  (5/26/22)
"The positive results could drive physician adoption when scheduling colonoscopies for hard-to-prepare patients going forward," noted an H.C. Wainwright & Co. report. More >

FDA Approves New Skin Resurfacing Device
Source: Streetwise Reports  (5/26/22)
Apyx Medical Corp. shares traded 50% higher after the company reported it received U.S. FDA 510(k) clearance for its Renuvion Dermal Handpiece for use in specific cosmetic dermal resurfacing procedures. More >

Ophthalmic Med Tech. Firm Sees 166% Gain in LAL Implants
Source: Streetwise Reports  (5/6/22)
Shares of RxSight Inc. traded 7% higher after the company reported Q1/22 financial results which highlighted a 157% YoY increase in revenue and a 208% increase in unit sales of its Light Delivery Devices (LDDâ„¢s) utilized in cataract surgery procedures to implant its RxSight Light Adjustable Lens® (LAL), which it says is "the world's first and only adjustable intraocular lens (IOL) that is customized after cataract surgery." More >

FDA Expands Use for Transcarotid Stent
Source: Streetwise Reports  (5/2/22)
Silk Road Medical Inc. shares traded 12% higher after the company reported that the U.S. FDA granted expanded authorization for its ENROUTE® transcarotid stent system for use in preventing stroke in patients deemed to be at standard risk for adverse events from carotid endarterectomy. More >

Surgical Device Maker's Shares Rise 7% on Q3 Earnings
Source: Streetwise Reports  (4/7/22)
Shares of AngioDynamics Inc. traded higher after the company reported Q3/22 financial results highlighting a 28.6% YoY increase in net Med Tech sales. More >

Shares Rise 10% After FDA Approval of Implantable Lens
Source: Streetwise Reports  (3/28/22)
STAAR Surgical Co. shares traded higher after the company reported that the U.S. FDA approved its EVO Visian® Implantable Collamer® Lenses to correct myopia (nearsightedness) and myopia with astigmatism. More >

Medical Device Co. Changes Tack to Drive Topline Growth
  (3/9/22)
This medical device company is improving its laser ablation system and working toward U.S. approval for its use in a second application, noted a Ladenburg Thalmann report. More >

Co. to Rebound After Q4/21 Sales Down Due to Virus Surge
  (3/1/22)
The 2022 outlook for a cancer detection and therapy solutions company is positive given its focus on dermatology and implementing new commercial strategies, noted an Oppenheimer report. More >

Dialysis Equip. Co. Posts Record FY21 Sales
Source: Streetwise Reports  (2/17/22)
Shares of a wireless mobile dialysis equipment maker traded 15% higher after the company reported FY/21 financial results highlighting a 105% YoY increase in revenue to $102.6 million. More >

FDA Approves First Tubeless Insulin Delivery Device
Source: Streetwise Reports  (1/28/22)
Shares of Insulet Corp. traded 15% higher after the company reported its Omnipod® 5 automated insulin delivery system has received clearance from the U.S. FDA. The Omnipod® 5 is the first tubeless system to be monitored and controlled remotely using a smartphone. More >

FDA Gives Fast Track Status to Firm for Adrenal Rescue Pen
  (1/24/22)
Now with fast track status and positive Phase 1 study results, Antares Pharma plans to advance its ATRS-1902 product candidate into a second trial in Q2/22, noted a Ladenburg Thalmann report. More >

Medical Device Firm Engages Distributor for Its TransDermal Infusion System
Source: Streetwise Reports  (12/6/21)
Sensus Healthcare's "needle-free treatment presents a clear competitive advantage in the aesthetic dermatology space," an H.C. Wainwright & Co. report noted. More >

Robotic Surgical Systems Co.'s Shares Gain 21% on Q3 Earnings and Forward Revenue Outlook
Source: Streetwise Reports  (11/11/21)
Stereotaxis Inc. shares traded higher after the company reported Q3/21 financial results and confirmed its FY/21 revenue guidance. The company added that it is sufficiently funded and is on pace towards doubling its system revenue in FY/22. More >

Robotic Surgical Device Maker's Shares Maneuver Higher on Q3 Earnings
Source: Streetwise Reports  (11/4/21)
Shares of robotic performance-guided surgery device maker Asensus Surgical Inc. traded 21% higher after the company reported Q3/21 financial results that included a 215% increase in YoY revenue. More >

SmileDirectClub Granted Patent for Mobile Oral Care Bus to Serve Remote Regions in the US & UK
Source: Streetwise Reports  (10/5/21)
SmileDirectClub Inc. shares traded 15% higher after the company reported that the U.S. Patent & Trademark Office has allowed its new patent for the firm's mobile SmileBus concept whereby its SmileShop on wheels is mobilized to expand access to convenient, affordable oral care in remote areas across the U.S. and the U.K. More >